Business Context and Reporting Period
Company: CorVel Corporation
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2008
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation and auto policies. The company operates in a single reportable segment (managed care) and serves insurance companies, third-party administrators, and self-administered employers.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2008 | Six Months Ended Sep 30, 2008 |
|---|---|---|
| Revenues | $77.9 million | $156.1 million |
| Net Income | $5.0 million | $10.5 million |
| Diluted EPS | $0.36 | $0.75 |
| Gross Margin | 24.2% | 24.9% |
| Operating Cash Flow (6mo) | $14.7 million | |
| Cash and Equivalents | $23.6 million (as of Sep 30, 2008) | |
| Debt | None (Line of credit expired and not renewed) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 5.9% ($4.3 million) for the quarter and 5.6% ($8.2 million) for the six-month period compared to the prior year. Growth was driven by increased volume in Patient Management services (up 9.0% quarterly) and Network Solutions services.
- Profitability Decline: Despite revenue growth, Net Income decreased 11.9% ($0.7 million) for the quarter and 5.9% ($0.7 million) for the six-month period. This was primarily due to a 14.1% increase in General and Administrative (G&A) expenses, driven by higher systems and data interface costs (e.g., new co-location center).
- Margin Compression: Gross profit margin declined from 25.4% to 24.2% for the quarter, attributed to a higher mix of lower-margin Patient Management services.
- Share Repurchases: The company repurchased 55,337 shares for $1.5 million during the quarter. The Board expanded the repurchase program authorization to 13.15 million shares in September 2008.
Outlook, Risks, and Contingencies
- Market Conditions: Management cites a challenging environment due to declining manufacturing employment (reducing workplace injuries), price competition, and potential changes in state workers' compensation laws. Revenue growth is expected to be difficult to attain.
- Internal Controls: The company disclosed that disclosure controls and procedures were not effective due to material weaknesses in accounts payable and financial close/reporting processes identified in the prior fiscal year. Remediation is ongoing, with new software implementation expected to be complete by the end of the fiscal year.
- Legal Proceedings: A putative class action lawsuit filed in 2005 by Kathleen Roche, D.C., regarding alleged failure to steer patients to PPO network providers and use of biased software, remains pending. The Illinois Supreme Court denied the company's appeal regarding class certification in September 2008. The company intends to vigorously defend the case, but a range of loss cannot be estimated.
- Stock-Based Compensation: The company reversed $250,000 in previously recognized stock-based compensation expense for performance options granted in 2006, as management determined earnings targets would not be met.
Investor Verification Checklist
- Remediation Progress: Verify the timeline and success of the new accounts payable software rollout and the remediation of material weaknesses in internal controls.
- Legal Exposure: Monitor developments in the Roche class action lawsuit, as a loss could be material.
- Expense Management: Assess whether the 14.1% increase in G&A expenses is a one-time step-up due to infrastructure investments or a recurring trend that will pressure future margins.
- Market Headwinds: Evaluate the impact of declining workers' compensation claims and manufacturing employment on future revenue growth projections.